ClinicalTrials.Veeva

Menu

Evaluation of the Clinical Efficacy of Moxibustion With Regulating Yin and Yang in the Treatment of Menopausal Obesity

H

Hubei Hospital of Traditional Chinese Medicine

Status

Unknown

Conditions

Obesity

Treatments

Device: Yin and Yang Regulating Moxibustion

Study type

Interventional

Funder types

Other

Identifiers

NCT04943705
HubeiHTCM

Details and patient eligibility

About

This study is designed as a two-dummy randomized controlled trial to evaluate the safety and superiority of Yin and Yang regulating moxibustion in the treatment of menopausal obese patients.

Full description

The study will be a multicenter, randomized, controlled trial, conducted from January 2021 to December 2022, including 216 menopausal obese patients who meet the inclusion criteria. The subjects will be randomly divided into 2 treatment groups: Yin and Yang regulating moxibustion group and mild moxibustion group. Each group of treatment will last for 12 weeks, with a follow-up period of 12 weeks. The main outcome indicator is waist circumference. The secondary outcome indicators include subjects related to obesity, TCM clinical syndrome score and modified Kupperman score, weight impact on quality of life scale (IWQOL-Lite), quality of life assessment health survey summary (SF-36). During the intervention period, adverse events will be recorded.

Enrollment

216 estimated patients

Sex

Female

Ages

40 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients who meet the diagnostic criteria for menopausal syndrome and obesity;
  2. Patients with BMI≥25 and waist circumference≥80cm;
  3. Female patients between 40-60 years old;
  4. Have not taken any hormone drugs or weight loss related drugs in the past 3 months;
  5. Sign the informed consent and voluntarily accept the intervention methods of this project.

Exclusion criteria

  1. Unexplained vaginal bleeding, or unnatural menopause;
  2. Have used hormone replacement therapy or other drugs related to this disease in the past 3 months;
  3. Combined with serious organic diseases, endocrine diseases, heart, liver and kidney, and respiratory diseases;
  4. Secondary obesity caused by hypothalamic lesions, hypothyroidism, glucocorticoid therapy, etc.;
  5. Combined with organic uterine diseases, such as polycystic ovary syndrome, malignant tumors, severe cervical erosion, after total hysterectomy, etc.;
  6. There are contraindications to moxibustion, such as moxibustion intolerance, skin allergies, scars, and other serious skin diseases;
  7. Poor compliance and unable to adhere to treatment.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

216 participants in 2 patient groups

Yin and Yang Regulating Moxibustion
Experimental group
Description:
1.The acupoints will be selected as Shenque and Mingmen.The location of the acupoints were based on the national GB/T 12346-2006 acupoints standard.Each treatment was 60min, once a week, Wenyang Yishen moxibustion and Peiyuan Guben moxibustion were performed alternately. Each patient received WenYang Yishen moxibustion and then Peiyuan Guben moxibustion for a total of 12 weeks of treatment and 12 weeks of follow-up at the end of the treatment. 2.The diet and exercise control implementation plan is as follows:Participants weighed ≤113.6 kg (250 lbs) and had a prescription diet of 1200-1499 kcal/day, including traditional foods, of which protein was about 15-20 kcal, fat was about 20-35%, and the rest came from carbohydrates. People weighing ≥113.6 kg are prescribed 1500-1800 kcal per day. They were also instructed to continue moderate-intensity physical activities (such as jogging, brisk walking) at least 5 days a week, at least 210 minutes a week, preferably ≥270 minutes a week。
Treatment:
Device: Yin and Yang Regulating Moxibustion
Mild Moxibustion
Active Comparator group
Description:
1.The acupoints will be selected as Zhongwan, Guanyuan, Sanyinjiao (double).The location of the acupoints were based on the national GB/T 12346-2006 acupoints standard.Light one end of the moxa stick and hang it about 2-3cm above the skin, taking the patient's local skin redness and conscious warmth as the degree. Moxa-box moxibustion will be used for 20 minutes each treatment, once every other day, 3 times a week, for a total of 12 weeks of treatment, and 12 weeks of follow-up after the treatment. 2.Lifestyle modification:It will be performed as the same as the Yin and Yang Regulating Moxibustion group.
Treatment:
Device: Yin and Yang Regulating Moxibustion

Trial contacts and locations

2

Loading...

Central trial contact

Wei Huang, professor; Zhong-Yu Zhou, professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems